Details for New Drug Application (NDA): 215252
✉ Email this page to a colleague
NDA 215252 describes DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%, which is a drug marketed by Exela Pharma and is included in one NDA. Additional details are available on the DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5% profile page.
The generic ingredient in DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5% is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
The generic ingredient in DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5% is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
Summary for 215252
| Tradename: | DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5% |
| Applicant: | Exela Pharma |
| Ingredient: | diltiazem hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | 125MG/125ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Oct 28, 2021 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | 250MG/250ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Oct 28, 2021 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
